Please ensure Javascript is enabled for purposes of website accessibility
Home / News / Government Federal / FDA’s fast-tracking of drugs called ‘risky’

FDA’s fast-tracking of drugs called ‘risky’

The Food and Drug Administration’s expedited approval of drugs like the blood thinner Pradaxa may be endangering U.S. consumers, according to a new column in the Journal of the American Medical Association. “Although enabling new drugs with a favorable benefit-to-harm balance to become available to patients more rapidly is a laudable goal, the underlying question is ...